Comparable with the results reported about WT1 expression in MPN, its expression is also higher in leukemia cells and LSCs compared to normal healthy hematopoietic cells and is a possible prognostic factor to predict clinical outcome and to detect MRD [203,204,205,206]. The gene discussed is WT1; the disease is myeloproliferative disorder.